MPLT vs WAT · $1.24B cap vs P/E 32, rev $3.17B
MapLight Therapeutics, Inc. Common Stock (MPLT) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
MPLT does not have a complete income-statement cache yet.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
MPLT currently screens at market cap $1.24B. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the MPLT and WAT stock pages for the full models.
Not investment advice.